Search details
1.
Engagement in care among youth living with parenterally-acquired HIV infection in Romania.
AIDS Care
; 31(10): 1290-1296, 2019 10.
Article
in English
| MEDLINE | ID: mdl-31056925
2.
Epidemiological characteristics and access to end-stage liver disease care for HIV-positive patients with HCV and/or HBV coinfections in Central/Eastern European and neighboring countries data from the ECEE network
Przegl Epidemiol
; 73(1): 61-68, 2019.
Article
in English
| MEDLINE | ID: mdl-31134775
3.
Choice of first-line antiretroviral therapy regimen and treatment outcomes for HIV in a middle income compared to a high income country: a cohort study.
BMC Infect Dis
; 16: 106, 2016 Mar 03.
Article
in English
| MEDLINE | ID: mdl-26939611
4.
Clinical relevance of the plasma load of cytomegalovirus in patients infected with HIV--a survival analysis.
J Med Virol
; 86(11): 1821-7, 2014 Nov.
Article
in English
| MEDLINE | ID: mdl-25087866
5.
Higher risk of renal impairment associated with tenofovir use amongst people living with HIV in India: a comparative cohort analysis between Western India and United Kingdom.
BMC Infect Dis
; 14: 173, 2014 Mar 29.
Article
in English
| MEDLINE | ID: mdl-24679159
6.
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012.
HIV Med
; 13 Suppl 2: 1-85, 2012 Sep.
Article
in English
| MEDLINE | ID: mdl-22830364
7.
Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1.
Nat Med
; 11(11): 1170-2, 2005 Nov.
Article
in English
| MEDLINE | ID: mdl-16205738
8.
The effect of HIV status on the frequency and severity of acute respiratory illness.
PLoS One
; 15(5): e0232977, 2020.
Article
in English
| MEDLINE | ID: mdl-32469981
9.
Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting: The RESPOND cohort consortium.
PLoS One
; 15(12): e0243625, 2020.
Article
in English
| MEDLINE | ID: mdl-33382756
10.
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.).
HIV Med
; 15 Suppl 1: 1-85, 2014 Jan.
Article
in English
| MEDLINE | ID: mdl-24330011
11.
Success of clinical care for human immunodeficiency virus infection according to demographic group among sexually infected patients in a routine clinic population, 1999 to 2004.
Arch Intern Med
; 167(7): 692-700, 2007 Apr 09.
Article
in English
| MEDLINE | ID: mdl-17420428
12.
The influence of HIV infection and antiretroviral therapy on the mitochondrial membrane potential of peripheral mononuclear cells.
Antivir Ther
; 12(5): 769-78, 2007.
Article
in English
| MEDLINE | ID: mdl-17713160
13.
Acetyl-L-carnitine in HIV-associated antiretroviral toxic neuropathy.
CNS Drugs
; 21 Suppl 1: 25-30; discussion 45-6, 2007.
Article
in English
| MEDLINE | ID: mdl-17696590
14.
Changes over time in risk of initial virological failure of combination antiretroviral therapy: a multicohort analysis, 1996 to 2002.
Arch Intern Med
; 166(5): 521-8, 2006 Mar 13.
Article
in English
| MEDLINE | ID: mdl-16534038
15.
Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers.
AIDS
; 20(1): 67-71, 2006 Jan 02.
Article
in English
| MEDLINE | ID: mdl-16327321
16.
A randomized trial to evaluate continuation versus discontinuation of lamivudine in individuals failing a lamivudine-containing regimen: the COLATE trial.
Antivir Ther
; 11(6): 761-70, 2006.
Article
in English
| MEDLINE | ID: mdl-17310820
17.
Concomitant use of an active boosted protease inhibitor with enfuvirtide in treatment-experienced, HIV-infected individuals: recent data and consensus recommendations.
HIV Clin Trials
; 7(2): 86-96, 2006.
Article
in English
| MEDLINE | ID: mdl-16798623
18.
Treatment intensification followed by interleukin-7 reactivates HIV without reducing total HIV DNA: a randomized trial.
AIDS
; 30(2): 221-30, 2016 Jan.
Article
in English
| MEDLINE | ID: mdl-26684819
19.
The relationship between CD4 cell count nadirs and the toxicity profiles of antiretroviral regimens.
Antivir Ther
; 10(3): 459-67, 2005.
Article
in English
| MEDLINE | ID: mdl-15918337
20.
A randomized trial to evaluate lopinavir/ritonavir versus saquinavir/ritonavir in HIV-1-infected patients: the MaxCmin2 trial.
Antivir Ther
; 10(6): 735-43, 2005.
Article
in English
| MEDLINE | ID: mdl-16218173